Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Go back to Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia| (NASDAQ: BNGO) | Delayed: 1.73 -0.01 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.74 | 52 Week High | $ | |||
| Open | $1.75 | 52 Week Low | $ | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $ | |||
| Volume | 1,197,614 | |||||
